Pasar al contenido principal

NUEVAS APROXIMACIONES DE VACUNACION MUCOSAL CONTRA LA TUBERCULOSIS EN EL MODELO CAPRINO: EVALUACION DE LA INMUNOGENICIDAD, EFICACIA Y EFECTOS EN EL DIAGNOSTICO

PID2022-142939OR-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario INSTITUT DE RECERCA I TECNOLOGIA AGROALIMENTARIES (IRTA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effects of different vaccination regimes on the immunodiagnosis of tuberculosis in goats and evaluation of defined antigens

  • Cuenca Lara, Patricia
  • Blay-Benach, Miriam
  • Cervera, Zoraida
  • Melgarejo, Cristian|||0000-0002-9570-753X
  • Moraleda, Julia
  • Sevilla, Iker A.|||0000-0003-3968-3390
  • Garrido, Joseba M.
  • Singh, Mahavir
  • Jones, Gareth J.
  • Pérez de Val, Bernat|||0000-0003-3127-9182
Tuberculosis (TB) in goats is a chronic infectious disease caused by Mycobacterium tuberculosis complex (MTBC) organisms that pose a great health and economic challenge for the caprine industry in some European and developing countries. It is also a zoonotic disease posing a risk for public health. The control programs of the disease are based on a test-and-slaughter strategy, and vaccination is not feasible with available vaccines due to its interferences with the current TB immunodiagnosis. There is still a need for the development of an effective TB vaccine and, concurrently, diagnostic methods that allow differentiation between infected and vaccinated animals (DIVA approach). In this study, we investigated the interferences caused by the tuberculin (PPD)-based TB diagnostic tests in goats immunized by different mucosal and parenteral vaccination strategies: three single-dose strategies based on intranasal administration of BCG and two heat-inactivated M. bovis (HIMB) vaccines, and two prime-boost strategies based on parenteral BCG or HIMB priming and intranasal HIMB boosting. In addition, the defined antigens ESAT-6, CPF10, and EspC were evaluated as alternative diagnostic reagents to PPDs. At week 14 after prime vaccination of the animals, skin tests, IFN- γ release assay, and antibody detection assays were performed. The two prime-boosted and the single-dose intranasal BCG groups displayed greater cell-mediated immune responses to PPDs than the two single-dose intranasal HIMB vaccines. However, the use of reagents based on the defined antigens eliminated or reduced the vaccine-induced diagnostic interferences in all groups. Based on these results, the use of defined antigens in the current immunodiagnostic tests appears to be suitable in a future goat TB vaccination scenario.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Effects of different vaccination regimes on the immunodiagnosis of tuberculosis in goats and evaluation of defined antigens

  • Cuenca-Lara, Patricia
  • Blay-Benach, Miriam
  • Cervera Muñoz, Zoraida
  • Melgarejo, Cristian
  • Moraleda, Julia
  • Sevilla, Iker A.
  • Garrido, Joseba M.
  • Singh, Mahavir
  • Jones, Gareth J.
  • Pérez de Val, Bernat
Tuberculosis (TB) in goats is a chronic infectious disease caused by Mycobacterium tuberculosis complex (MTBC) organisms that pose a great health and economic challenge for the caprine industry in some European and developing countries. It is also a zoonotic disease posing a risk for public health. The control programs of the disease are based on a test-and-slaughter strategy, and vaccination is not feasible with available vaccines due to its interferences with the current TB immunodiagnosis. There is still a need for the development of an effective TB vaccine and, concurrently, diagnostic methods that allow differentiation between infected and vaccinated animals (DIVA approach). In this study, we investigated the interferences caused by the tuberculin (PPD)-based TB diagnostic tests in goats immunized by different mucosal and parenteral vaccination strategies: three single-dose strategies based on intranasal administration of BCG and two heatinactivated M. bovis (HIMB) vaccines, and two prime-boost strategies based on parenteral BCG or HIMB priming and intranasal HIMB boosting. In addition, the defined antigens ESAT-6, CPF10, and EspC were evaluated as alternative diagnostic reagents to PPDs. At week 14 after prime vaccination of the animals, skin tests, IFN-γ release assay, and antibody detection assays were performed. The two prime-boosted and the single-dose intranasal BCG groups displayed greater cellmediated immune responses to PPDs than the two single-dose intranasal HIMB vaccines. However, the use of reagents based on the defined antigens eliminated or reduced the vaccine-induced diagnostic interferences in all groups. Based on these results, the use of defined antigens in the current immunodiagnostic tests appears to be suitable in a future goat TB vaccination scenario., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The study was funded by grants from the Spanish Ministry of Science and Innovation (Ref. PID2022-142939OR-C22) and the European Commission (INNOTUB II – EFA115/01, Interreg POCTEFA 2021–2027 program, co-funded by the ERDF). IRTA is supported by Centres de Recerca de Catalunya (CERCA) Program/Generalitat de Catalunya (www.cerca.cat)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Phagocytosis of Mycobacterium fortuitum by Caprine Alveolar Macrophages Is Associated with iNOS and Pro-Inflammatory Markers Expression

  • Blay-Benach, Miriam
  • Cuenca-Lara, Patricia
  • Repullés, Joan
  • Cervera, Zoraida
  • Pérez de Val, Bernat
Mycobacterial diseases, including tuberculosis (TB), remain the major health and economic challenges in livestock, underscoring the need to characterise the innate immune mechanisms involved in early bacterial containment. Alveolar macrophages (AMs) are the first line of defence against inhaled mycobacteria, yet the functional links between activation, polarisation, and phagocytic capacity in caprine AMs remain poorly defined. In this study, we compared a pH-dependent live-cell fluorescence assay with a culture-based method to evaluate phagocytosis and clearance of Mycobacterium fortuitum under different immunostimulatory conditions. AMs were stimulated in vitro with LPS or heat-inactivated Mycobacterium bovis (HIMB), and phagocytosis was assessed alongside activation and pro-inflammatory markers. Both approaches showed that LPS stimulation significantly enhanced mycobacterial clearance, despite reduced initial bacterial uptake. Moreover, this improved phagocytic capacity was associated with increased expression of the inducible Nitric Oxide Synthase (iNOS), MHCII, CD80, and CD86, as well as an elevated production of some pro-inflammatory cytokines. In contrast, HIMB induced cytokine secretion but failed to enhance activation markers or bacterial clearance. Collectively, these results establish the first association between pro-inflammatory activation and functional mycobacterial phagocytosis in caprine AMs and validate a robust methodological framework for studying innate immune responses relevant to TB and vaccine development in goats, This work was funded by the Spanish Ministry of Science, Innovation and Universities (MICIU/AEI/10.13039/501100011033) with the Grant PID2022-142939OR-C22 and the European Commission (Interreg POCTEFA 2021–2027 program) with the Grant INNOTUB II–EFA115/01 and co-funded by the ERDF. IRTA-CReSA is also supported by the Centres de Recerca de Catalunya (CERCA) Program of the Generalitat de Catalunya (www.cerca.cat)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Intranasal BCG vaccination induces systemic and pulmonary mucosal immune responses against tuberculosis in a goat model

  • Cuenca-Lara, Patricia
  • Blay-Benach, Miriam
  • Cervera, Zoraida
  • Moraleda, Julia
  • Sevilla, Iker A.
  • Garrido, Joseba M.
  • Singh, Mahavir
  • Lopez-Soria, Sergio
  • Vidal, Enric
  • Domingo, Mariano
  • Pérez de Val, Bernat
Early immune containment of mycobacteria at the infection site is key to tuberculosis (TB) vaccine development. Intranasal delivery strategies offer a promising alternative to parenteral BCG vaccination, particularly for pulmonary TB, the predominant clinical form in humans and livestock. This study evaluated the immunogenicity of intranasal BCG and heat-inactivated M. bovis (HIMB) with or without adjuvant, as well as prime-boost strategies combining parenteral BCG or HIMB followed by intranasal HIMB in young goats. Intranasal BCG elicited systemic antigen-specific IFNγ production, with enhanced expansion of CD4+IFNγ+ and CD8+IFNγ+ T-cells, comparable to prime-boost regimens. Intranasal BCG and prime-boosted groups also induced higher local proinflammatory responses at the lung mucosa, including proinflammatory cytokine production, expansion of antigen-specific T-cells, and polarization of alveolar macrophages toward activated proinflammatory phenotype. The results underscore the potential of respiratory mucosal BCG delivery to enhance early immune responses against TB infection and support further investigation into its protective efficacy., The author(s) declared that financial support was received for this work and/or its publication. The study was funded by the Grant PID2022-142939OR-C22 of the Spanish Ministry of Science, Innovation and Universities (MICIU/AEI/10.13039/501100011033), the Grant INNOTUB II – EFA115/01 of the European Commission (Interreg POCTEFA 2021–2027 program) and the ERDF. IRTA is supported by the Centres de Recerca de Catalunya (CERCA) Program of the Generalitat de Catalunya (www.cerca.cat)., info:eu-repo/semantics/publishedVersion
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

In vitro priming with Mycobacterium fortuitum induces trained immunity-associated phenotypes in caprine alveolar macrophages and enhances phagosomal maturation and antimicrobial functions upon homologous re-stimulation

  • Blay Benach, Miriam
  • Cuenca Lara, Patricia
  • Moraleda, Julia
  • Cervera Muñoz, Zoraida
  • Repullés Fernández, Joan
  • Pérez de Val, Bernat
Background: Trained immunity refers to the stimuli-induced epigenetic and metabolic reprogramming of innate immune cells, enabling enhanced non-specific responses upon secondary stimulation. Alveolar macrophages (AMs) constitute the primary immune barrier in the lung and represent a key target in enhancing protection against pulmonary pathogens.Methods: In this study, an in vitro priming-resting-re-stimulation protocol was used to characterise the ability of Mycobacterium fortuitum (MF) to induce functional features of trained immunity in caprine AMs in vitro. Pro-inflammatory cytokines (TNFα, IL-1β, IL-6) and nitric oxide synthase (iNOS)-positive cells were quantified by multiplex assay and flow cytometry, respectively. Phagosomal acidification was detected by flow cytometry and live-cell fluorescent microscopy after MF-challenge using pH-sensitive labelled bacteria.Results: MF-trained AMs displayed significantly elevated TNFα and IL-1β production and a higher frequency of inducible iNOS-producing cells compared to non-stimulated controls, consistent with a trained immunity-associated pro-inflammatory and antimicrobial phenotype. Phagosomal acidification was enhanced and sustained in MF-trained AMs following homologous challenge with MF, suggesting enhanced phagocytic activity against mycobacteria.Conclusion: These findings provide evidence that M. fortuitum induces trained immunity-associated functional responses in caprine AMs and support further trained immunity studies in the caprine lung mucosa against pulmonary infections., The author(s) declared that financial support was received for this work and/or its publication. This work was funded by the Spanish Ministry of Science, Innovation and Universities (MICIU/AEI/10.13039/501100011033) with the Grant PID2022-142939OR-C22 and the European Commission (Interreg POCTEFA 2021–2027 program) with the Grant INNOTUB II–EFA115/01 and co-funded by the ERDF. IRTA-CReSA is also supported by the Centres de Recerca de Catalunya (CERCA) Program of the Generalitat de Catalunya (https://www.cerca.cat)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Effects of different vaccination regimes on the immunodiagnosis of tuberculosis in goats and evaluation of defined antigens

  • Cuenca-Lara, Patricia
  • Blay-Benach, Miriam
  • Cervera Muñoz, Zoraida
  • Melgarejo, Cristian
  • Moraleda, Julia
  • Sevilla, Iker A.
  • Garrido, Joseba M.
  • Singh, Mahavir
  • Jones, Gareth J.
  • Pérez de Val, Bernat
Tuberculosis (TB) in goats is a chronic infectious disease caused by Mycobacterium tuberculosis complex (MTBC) organisms that pose a great health and economic challenge for the caprine industry in some European and developing countries. It is also a zoonotic disease posing a risk for public health. The control programs of the disease are based on a test-and-slaughter strategy, and vaccination is not feasible with available vaccines due to its interferences with the current TB immunodiagnosis. There is still a need for the development of an effective TB vaccine and, concurrently, diagnostic methods that allow differentiation between infected and vaccinated animals (DIVA approach). In this study, we investigated the interferences caused by the tuberculin (PPD)-based TB diagnostic tests in goats immunized by different mucosal and parenteral vaccination strategies: three single-dose strategies based on intranasal administration of BCG and two heatinactivated M. bovis (HIMB) vaccines, and two prime-boost strategies based on parenteral BCG or HIMB priming and intranasal HIMB boosting. In addition, the defined antigens ESAT-6, CPF10, and EspC were evaluated as alternative diagnostic reagents to PPDs. At week 14 after prime vaccination of the animals, skin tests, IFN-γ release assay, and antibody detection assays were performed. The two prime-boosted and the single-dose intranasal BCG groups displayed greater cellmediated immune responses to PPDs than the two single-dose intranasal HIMB vaccines. However, the use of reagents based on the defined antigens eliminated or reduced the vaccine-induced diagnostic interferences in all groups. Based on these results, the use of defined antigens in the current immunodiagnostic tests appears to be suitable in a future goat TB vaccination scenario., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The study was funded by grants from the Spanish Ministry of Science and Innovation (Ref. PID2022-142939OR-C22) and the European Commission (INNOTUB II – EFA115/01, Interreg POCTEFA 2021–2027 program, co-funded by the ERDF). IRTA is supported by Centres de Recerca de Catalunya (CERCA) Program/Generalitat de Catalunya (www.cerca.cat)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Phagocytosis of Mycobacterium fortuitum by Caprine Alveolar Macrophages Is Associated with iNOS and Pro-Inflammatory Markers Expression

  • Blay-Benach, Miriam
  • Cuenca-Lara, Patricia
  • Repullés, Joan
  • Cervera, Zoraida
  • Pérez de Val, Bernat
Mycobacterial diseases, including tuberculosis (TB), remain the major health and economic challenges in livestock, underscoring the need to characterise the innate immune mechanisms involved in early bacterial containment. Alveolar macrophages (AMs) are the first line of defence against inhaled mycobacteria, yet the functional links between activation, polarisation, and phagocytic capacity in caprine AMs remain poorly defined. In this study, we compared a pH-dependent live-cell fluorescence assay with a culture-based method to evaluate phagocytosis and clearance of Mycobacterium fortuitum under different immunostimulatory conditions. AMs were stimulated in vitro with LPS or heat-inactivated Mycobacterium bovis (HIMB), and phagocytosis was assessed alongside activation and pro-inflammatory markers. Both approaches showed that LPS stimulation significantly enhanced mycobacterial clearance, despite reduced initial bacterial uptake. Moreover, this improved phagocytic capacity was associated with increased expression of the inducible Nitric Oxide Synthase (iNOS), MHCII, CD80, and CD86, as well as an elevated production of some pro-inflammatory cytokines. In contrast, HIMB induced cytokine secretion but failed to enhance activation markers or bacterial clearance. Collectively, these results establish the first association between pro-inflammatory activation and functional mycobacterial phagocytosis in caprine AMs and validate a robust methodological framework for studying innate immune responses relevant to TB and vaccine development in goats, This work was funded by the Spanish Ministry of Science, Innovation and Universities (MICIU/AEI/10.13039/501100011033) with the Grant PID2022-142939OR-C22 and the European Commission (Interreg POCTEFA 2021–2027 program) with the Grant INNOTUB II–EFA115/01 and co-funded by the ERDF. IRTA-CReSA is also supported by the Centres de Recerca de Catalunya (CERCA) Program of the Generalitat de Catalunya (www.cerca.cat)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

In vitro priming with Mycobacterium fortuitum induces trained immunity-associated phenotypes in caprine alveolar macrophages and enhances phagosomal maturation and antimicrobial functions upon homologous re-stimulation

  • Blay Benach, Miriam
  • Cuenca Lara, Patricia
  • Moraleda, Julia
  • Cervera Muñoz, Zoraida
  • Repullés Fernández, Joan
  • Pérez de Val, Bernat
Background: Trained immunity refers to the stimuli-induced epigenetic and metabolic reprogramming of innate immune cells, enabling enhanced non-specific responses upon secondary stimulation. Alveolar macrophages (AMs) constitute the primary immune barrier in the lung and represent a key target in enhancing protection against pulmonary pathogens.Methods: In this study, an in vitro priming-resting-re-stimulation protocol was used to characterise the ability of Mycobacterium fortuitum (MF) to induce functional features of trained immunity in caprine AMs in vitro. Pro-inflammatory cytokines (TNFα, IL-1β, IL-6) and nitric oxide synthase (iNOS)-positive cells were quantified by multiplex assay and flow cytometry, respectively. Phagosomal acidification was detected by flow cytometry and live-cell fluorescent microscopy after MF-challenge using pH-sensitive labelled bacteria.Results: MF-trained AMs displayed significantly elevated TNFα and IL-1β production and a higher frequency of inducible iNOS-producing cells compared to non-stimulated controls, consistent with a trained immunity-associated pro-inflammatory and antimicrobial phenotype. Phagosomal acidification was enhanced and sustained in MF-trained AMs following homologous challenge with MF, suggesting enhanced phagocytic activity against mycobacteria.Conclusion: These findings provide evidence that M. fortuitum induces trained immunity-associated functional responses in caprine AMs and support further trained immunity studies in the caprine lung mucosa against pulmonary infections., The author(s) declared that financial support was received for this work and/or its publication. This work was funded by the Spanish Ministry of Science, Innovation and Universities (MICIU/AEI/10.13039/501100011033) with the Grant PID2022-142939OR-C22 and the European Commission (Interreg POCTEFA 2021–2027 program) with the Grant INNOTUB II–EFA115/01 and co-funded by the ERDF. IRTA-CReSA is also supported by the Centres de Recerca de Catalunya (CERCA) Program of the Generalitat de Catalunya (https://www.cerca.cat)., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Intranasal BCG vaccination induces systemic and pulmonary mucosal immune responses against tuberculosis in a goat model

  • Cuenca-Lara, Patricia
  • Blay-Benach, Miriam
  • Cervera, Zoraida
  • Moraleda, Julia
  • Sevilla, Iker A.
  • Garrido, Joseba M.
  • Singh, Mahavir
  • Lopez-Soria, Sergio
  • Vidal, Enric
  • Domingo, Mariano
  • Pérez de Val, Bernat
Early immune containment of mycobacteria at the infection site is key to tuberculosis (TB) vaccine development. Intranasal delivery strategies offer a promising alternative to parenteral BCG vaccination, particularly for pulmonary TB, the predominant clinical form in humans and livestock. This study evaluated the immunogenicity of intranasal BCG and heat-inactivated M. bovis (HIMB) with or without adjuvant, as well as prime-boost strategies combining parenteral BCG or HIMB followed by intranasal HIMB in young goats. Intranasal BCG elicited systemic antigen-specific IFNγ production, with enhanced expansion of CD4+IFNγ+ and CD8+IFNγ+ T-cells, comparable to prime-boost regimens. Intranasal BCG and prime-boosted groups also induced higher local proinflammatory responses at the lung mucosa, including proinflammatory cytokine production, expansion of antigen-specific T-cells, and polarization of alveolar macrophages toward activated proinflammatory phenotype. The results underscore the potential of respiratory mucosal BCG delivery to enhance early immune responses against TB infection and support further investigation into its protective efficacy., The author(s) declared that financial support was received for this work and/or its publication. The study was funded by the Grant PID2022-142939OR-C22 of the Spanish Ministry of Science, Innovation and Universities (MICIU/AEI/10.13039/501100011033), the Grant INNOTUB II – EFA115/01 of the European Commission (Interreg POCTEFA 2021–2027 program) and the ERDF. IRTA is supported by the Centres de Recerca de Catalunya (CERCA) Program of the Generalitat de Catalunya (www.cerca.cat)., info:eu-repo/semantics/publishedVersion